Join
Live feed
·
PRReleasevia Quantisnow
Sesen Bio Inc. logo

Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connection with Pending Merger with Carisma Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
SESN· Sesen Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SESN (Sesen Bio Inc.) and more on Quantisnow.